Article metrics

  • citations in SCindeks: 0
  • citations in CrossRef:0
  • citations in Google Scholar:[=>]
  • visits in previous 30 days:7
  • full-text downloads in 30 days:3
article: 2 from 2  
Back back to result list
Medicinski pregled
2011, vol. 64, iss. 9-10, pp. 481-485
article language: Serbian
document type: Professional Paper
doi:10.2298/MPNS1110481M


Frequency of vancomycin-resistant Enterococci isolated from blood cultures from 2008 to 2010
Institut za javno zdravlje Vojvodine, Centar za mikrobiologiju, Novi Sad

e-mail: mikrobiologija@izjzv.org.rs

Abstract

Introduction. Enterococci are important hospital-acquired pathogens. The most commonly isolated species of the genus, Enterococcus faecalis and Enterococcus faecium are the third to fourth-most prevalent nosocomial pathogens worldwide. The aim of this study was to determine the frequency of resistance to vancomycin and other antimicrobial agents of Enterococcus spp strains isolated from blood cultures of hospitalized patients. Material and methods. During the three-year period, from 2008 to 2010, 132 strains of Enterococcus spp isolated from blood cultures of hospitalized patients were tested for their susceptibility to ampicillin, vancomycin, gentamycin (high-level resistance), erythromycin, chloramphenicol, teicoplanin, ciprofloxacin by disc diffusion method according to the Clinical and Laboratory Standards Institute recommendations. Susceptibility of vancomycin resistant E. faecium to the same antibiotics and to linezolid, quinopristin/dalfopristin and tigecyclin was determined using VITEK system. Results and discussion. Resistance to vancomycin was detected in 21 (15.9%) Enterococcus spp strains. The percentage of resistance to other antimicrobial agents varied from 23.1% for chloramphenicol to 81.3% for ciproflxacin. All vancomycin resistant enterococci were identified as E. faecium and belonged to phenotype VanA. The resistance to other antibiotics was very high, except for linezolid and quinopristin/dalfopristin (4.7%). The high-level aminoglycoside resistance was 87.6% for gentamycin and 95.2% for streptomycin. All isolates were resistant to ampicillin, teicoplanin and ciprofloxacin. Conclusion. The detected high frequency of multidrug-resistant isolates among vancomycin resistant enterococci is of great importance and suggests the need for further monitoring of susceptibility in order to take adequate measures to prevent and control spreading of resistant strains.

Keywords

References

*** (2008) European Antimicrobial Resistance Surveillance System. EARSS, Annual report, www.ecdc.europa.eu/EARS-Net/2008_EARS_Annual_Report.pdf
*** (2010) Antimicrobial resistance in Europe 2009: Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC
Arthur, M., Courvalin, P. (1993) Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrobial agents and chemotherapy, 37(8): 1563-71
Bager, F., Madsen, M., Christensen, J., Aarestrup, F.M. (1997) Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms. Preventive veterinary medicine, 31(1-2): 95-112
Bates, J. (1997) Epidemiology of vancomycin-resistant enterococci in the community and the relevance of farm animals to human infection. Journal of hospital infection, 37(2): 89-101
Bourdon, N., Fines-Guyon, M., Thiolet, J.M., Mougat, S., Coignard, B., Leclercq, R., i dr. (2011) Changing trends in vancomycin-resistant enterococci in French hospitals, 2001-08. J Antimicrob Chemother, 66(4), str. 713-21
Brown, D.E., Hope, R., Livermore, D.M., Brick, G., Broughton, K., George, R.C., i dr. (2008) Non-susceptibility trends among enterococci and non-pneumococcal streptococci from bacteraemias in the UK and Ireland, 2001-06. J Antimicrob Chemother, 62 (Suppl 2):II75-85
Centers for Disease Control and Prevention (1955) Recommendation for preventing spread of vancomycin resistance. Hospital Infection Control Practices Advisory Committee (HICPAC). Infect Control Hosp Epidemiol., 16:105-13
Chou, Y., Lin, T., Lin, J., Wang, N., Peng, M., Chang, F. (2008) Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 41(2): 124-9
Diaz, G.C.A., Jernigan, J.A. (2005) Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection. Journal of infectious diseases, 191(4): 588-95
Edmond, M.B., Wallace, S.E., McClish, D.K., Pfaller, M.A., Jones, R.N., Wenzel, R.P. (1999) Nosocomial bloodstream infections in United States hospitals: A three-year analysis. Clin Infect Dis, 29(2): 239-44
Eliopoulos, G.M., Wennersten, C.B., Gold, H.S., Moellering, R.C. (1996) In vitro activities in new oxazolidinone antimicrobial agents against enterococci. Antimicrobial agents and chemotherapy, 40(7): 1745-7
Fines, M., Perichon, B., Reynolds, P., Sahm, D.F., Courvalin, P., van E. (1999) A new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrob Agents Chemother, 42, str. 2161-4
Galdiero, E., Villari, P., di Onofrio, V., Pisciotta, M.G., Lucariello, A., Sommese, L., Liguori, G. (2005) Characterization of glycopeptide resistant enterococci isolated from a hospital in Naples (Italy). new microbiologica, 28(2): 171-6
Goossens, H. (1998) Spread of vancomycin-resistant enterococci: Differences between the United States and Europe. Infection control and hospital epidemiology, 19(8): 546-51
Heath, C.H., Blackmore, T.K., Gordon, D.L. (1996) Emerging resistance in Enterococcus spp. Medical journal of Australia, 164(2): 116-20
Kalauzov, M., Medić, D., Jovanović, J., Mihajlović-Ukropina, M., Stefan-Mikić, S., Sević, S. (2008) Rezistencija na antimikrobne lekove bakterija izolovanih iz hemokultura tokom 2007. godine. Med Pregl, 61(Suppl 1), str. 21-6
Klare, I., Badstübner, D., Konstabel, C., Böhme, G., Claus, H., Witte, W. (1999) Decreased incidence of VanA-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry. Microbial drug resistance, 5(1): 45-52
Lester, C.H., Sandvang, D., Olsen, S.S., Schønheyder, H.C., Jarløv, J.O., Bangsborg, J., Hansen, D.S., Jensen, T.G., Frimodt-Møller, N., Hammerum, A.M. (2008) Emergence of ampicillin-resistant Enterococcus faecium in Danish hospitals. Journal of antimicrobial chemotherapy, 62(6): 1203-6
Low, D.E., Keller, N., Barth, A., Jones, R.N. (2001) Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: Results from the SENTRY Antimicrobial Surveillance program, 1997-1999. Clin Infect Dis, 32:(Suppl 2):S133-45
McDonald, L.C., Kuehnert, M.J., Tenover, F.C., Jarvis, W.R. (1997) Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications. Emerging infectious diseases, 3(3): 311-7
Murray, B.E. (2000) Vancomycin-resistant enterococcal infections. N Engl J Med, 342(10): 710-21
National Committee for Clinical Laboratory Standards (2010) Performance standards for antimicrobial susceptibility testing. in: 20th international supplement, M100-S20, Wayne, PA: National Committee for Clinical Laboratory Standards
Schaberg, D.R., Culver, D.H., Gaynes, R.P. (1991) Major trends in the microbial etiology of nosocomial infection. Am J Med, 91(3B): 72S-75S
Sood, S., Malhotra, M., Das, B.K., Kapil, A. (2008) Enterococcal infection and antimicrobial resistance. Indian J. Med. Res., 128, str. 111-21
Talebi, M., Eshraghi, S.S., Pourshafie, M.R., Pourmand, M.R., Eshraghian, M.R. (2007) Characterization of vancomycin resistant Enterococcus faecalis. Iranian J. Publ. Health, 36(4), str. 20-5
Teixeira, L.M., Facklan, R.R. (2003) Enterococcus. in: Murray P.R., Baron E.J., Jorgensen J.H., Pealler M.A., Yolken R.H. [ed.] Manuual of clinical microbiology, Washington: ASM Press, 8th ed., str. 423-33
Treitman, A.N., Yarnold, P.R., Warren, J., Noskin, G. (2002) Emerging incidence of Enterococcus faecium among hospital isolates 1993-2002. J. Clin. Microbiol., 43, str. 462-3
Uttley, A.H., Collins, C.H., Naidoo, J., George, R.C. (1988) Vancomycin-resistant enterococci. Lancet, 1(8575-6): 57-8
van Schaik, W., Top, J., Riley, D.R., Boekhorst, J., Vrijenhoek, J.E.P., Schapendonk, C.M.E., Hendrickx, A.P.A., Nijman, I.J., Bonten, M.J.M., Tettelin, H., Willems, R.J.L. (2010) Pyrosequencing-based comparative genome analysis of the nosocomial pathogen Enterococcus faecium and identification of a large transferable pathogenicity island. BMC genomics, 11: 239
Werner, G., Coque, T.M., Hammerum, A.M., Hope, R., Hryniewicz, W., Johnson, A., i dr. (2008) Emergence and spread of vancomycin resistance among enterococci in Europe. Eurosurveillance, 13(47), str. 5-18
Wisplinghoff, H., Bischoff, T., Tallent, S.M., Seifert, H., Wenzel, R.P., Edmond, M.B. (2004) Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clinical infectious diseases, 39(3): 309-17